News

Videos

July, 2024

Juvena shares updates with the DM community about our muscle regenerating fusion protein, JUV-161 in the “Meet the Myotonic Dystrophy Drug Developers” webinarWatch Now »

June, 2024

CEO Dr. Yousef represents Juvena as a Technology Pioneer at at the World Economic Forum’s Annual Meeting of the New Champions, a.k.a. Summer Davos, in Dalian, China, speaking on “Revolutionary Remedies” and “Letting Biotech Breath”Watch Now »

June, 2024

CEO Dr. Hanadie Yousef represents Juvena on 2 panels at BIO San Diego to discuss navigating the frontiers of First-in-Class therapeutics, and how healthspan promoting therapeutics are entering the biopharma mainstream.Watch Now »

June, 2024

Longevity Technology highlights Juvena and others from the Longevity Summer DublinWatch Now »

June, 2024

AFAR: AI For Longevity Drug Discovery: Breakthrough and Challenges WebinarWatch Now »

April, 2024

Jeremy O’Connell presents video discussing JUV-161 for myotonic dystrophy type 1 (DM1)Watch Now »

August, 2023

EARD 2023 Panel, “Is Aging Truly Reversible” Featuring CEO Dr. Hanadie YousefWatch Now »

July, 2023

Wuxi spotlights Juvena in their BOLD: Innovation that Matters episode 3 focused on rare diseases. Check out Hanadie’s preview of Juvena’s JUV-161 program (1:58)Watch Now »

December, 2022

Juvena’a CEO, Dr. Hanadie Yousef discusses “Harnessing the Regenerative Secretome of Human Pluripotent Stem Cells” with other industry leaders discussing key areas of innovation advancing human healthspan and longevity at the Second Annual Longevity SummitWatch Now »

November, 2022

Annual BioFuture 2022 Event Recognizes Juvena CEO Dr. Hanadie Yousef Among Longevity Pioneers Shaping Expectations in Healthcare and Celebrates the Company’s Series A AnnouncementWatch Now »

August, 2022

EARD 2022: Mapping Secreted Proteins to Unmet Medical Needs by Dr. Thach Mai at Juvena August 2022Watch Now »

Hanadie-served-on-a-CEO-panel-with-a-group-of-portfolio-companies-for-Bascom-Ventures--thumbs

December, 2021

Hanadie served on a CEO panel with a group of portfolio companies for Bascom Ventures (part of Alumni Ventures)Watch Now »

CEO-Dr.-Yousef-Represents-Juvena-at-Longevity-Summit-2021-Thumb

November, 2021

CEO Dr. Yousef Represents Juvena at Longevity Summit 2021Watch Now »

CEO-Dr.-Yousef-Represents-Juvena-at-Metabesity-2021-thumb

October, 2021

CEO Dr. Yousef Represents Juvena at Metabesity 2021Watch Now »

August, 2021

CEO Dr. Hanadie Yousef is interviewed by Ira Pastor for his Progress, Potential, and Possibilities show on Juvena’s development of Secretome Derived TherapiesWatch Now »

Juvena-Therapeutics-Presents-at-the-Muscular-Dystrophy-Association-Insights-in-Research-Investor-Summit-thumb

April, 2021

Juvena Therapeutics Presents at the Muscular Dystrophy Association Insights in Research Investor SummitWatch Now »

Juvena-Therapeutics-Interviewed-by-Fortune-Jan.-2021-thumb

February, 2021

Juvena Therapeutics Interviewed by Fortune Jan. 2021Watch Now »

Juvena-Therapeutics-Presents-at-the-International-Longevity-Alliance-Conference-Workshop-Feb-2021-thumb

February, 2021

Juvena Therapeutics Presents at the International Longevity Alliance Conference Workshop Feb 2021Watch Now »

Juvena-Therapeutics-at-Metabesity-Oct-2020-Conference-thumb

October, 2020

Juvena Therapeutics at Metabesity Oct 2020 ConferenceWatch Now »

Ending-Age-Related-Diseases-Conference-August-2020-thumb

August, 2020

Ending Age-Related Diseases Conference August 2020Watch Now »

Navigation

Contact

640 Galveston Drive
Redwood City, CA 94063
Get Directions »
650.223.5879
info@juvenatherapeutics.com

Stay in touch

Subscribe to our newsletter

By entering your email you agree to our Privacy Policy

© 2023 Juvena Therapeutics Inc. All Rights Reserved | Privacy Policy